These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16184026)

  • 1. Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.
    Legrand FA; Abadi J; Jordan KA; Davenport MP; Deeks SG; Fennelly GJ; Wiznia AA; Nixon DF; Rosenberg MG
    AIDS; 2005 Oct; 19(15):1575-85. PubMed ID: 16184026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
    Plana M; Martínez C; García F; Maleno MJ; Barceló JJ; García A; Lejeune M; Vidal C; Cruceta A; Miró JM; Pumarola T; Gallart T; Gatell JM
    J Acquir Immune Defic Syndr; 2002 Apr; 29(5):429-34. PubMed ID: 11981357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children.
    Abadi J; Sprecher E; Rosenberg MG; Dobroszycki J; Sansary J; Fennelly G; Wiznia A
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):298-303. PubMed ID: 16540930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.
    Resino S; Abad ML; Navarro J; Bellón JM; Sánchez-Ramón S; Angeles Muñoz-Fernández M
    Clin Exp Immunol; 2003 Jan; 131(1):130-7. PubMed ID: 12519396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The independent effect of drug resistance on T cell activation in HIV infection.
    Hunt PW; Deeks SG; Bangsberg DR; Moss A; Sinclair E; Liegler T; Bates M; Tsao G; Lampiris H; Hoh R; Martin JN
    AIDS; 2006 Mar; 20(5):691-9. PubMed ID: 16514299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
    García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM
    AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV.
    Palma P; Romiti ML; Cancrini C; Pensieroso S; Montesano C; Santucci MB; Bernardi S; Martino AM; Rossi P; Castelli-Gattinara G
    AIDS; 2007 Nov; 21(18):2465-72. PubMed ID: 18025883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART.
    Romiti ML; Cancrini C; Castelli-Gattinara G; Di Cesare S; Ciaffi P; Bernardi S; De Gasperi MR; Halapi E; Rossi P
    AIDS; 2001 Nov; 15(16):2075-84. PubMed ID: 11684926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.
    Lederman MM; McKinnis R; Kelleher D; Cutrell A; Mellors J; Neisler M; Cooney E; Haas DW; Haubrich R; Stanford J; Horton J; Landay A; Spreen W
    AIDS; 2000 Dec; 14(17):2635-42. PubMed ID: 11125881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.
    Sandberg JK; Fast NM; Jordan KA; Furlan SN; Barbour JD; Fennelly G; Dobroszycki J; Spiegel HM; Wiznia A; Rosenberg MG; Nixon DF
    J Immunol; 2003 Apr; 170(8):4403-10. PubMed ID: 12682278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
    Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ
    J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
    Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
    BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
    Klein N; Sefe D; Mosconi I; Zanchetta M; Castro H; Jacobsen M; Jones H; Bernardi S; Pillay D; Giaquinto C; Walker AS; Gibb DM; De Rossi A;
    PLoS One; 2013; 8(10):e76582. PubMed ID: 24194841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatment.
    Chougnet C; Fowke KR; Mueller BU; Smith S; Zuckerman J; Jankelevitch S; Steinberg SM; Luban N; Pizzo PA; Shearer GM
    AIDS; 1998 Dec; 12(18):2397-406. PubMed ID: 9875577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy.
    Ghaffari G; Passalacqua DJ; Caicedo JL; Goodenow MM; Sleasman JW
    Pediatrics; 2004 Nov; 114(5):e604-11. PubMed ID: 15492356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection.
    García F; Plana M; Ortiz GM; Bonhoeffer S; Soriano A; Vidal C; Cruceta A; Arnedo M; Gil C; Pantaleo G; Pumarola T; Gallart T; Nixon DF; Miró JM; Gatell JM
    AIDS; 2001 Jun; 15(9):F29-40. PubMed ID: 11416735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.